Becton, Dickinson and Company BDX Business Segments
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue, remaining performance obligation, amount by Product | ||||||
| Consumables | $9B-2.2% | $9.2B+4.5% | $8.8B+2.3% | $8.6B+2.4% | $8.4B+1.2% | |
| Products and/or Services | $10.1B-1.0% | $10.2B+2.0% | $10B+5.3% | $9.5B+2.2% | $9.3B+1.1% | |
| Revenue by Geography | ||||||
| International | $8.69B+1.1% | $8.59B0.0% | $8.59B+1.8% | $8.44B+2.8% | $8.21B-5.0% | |
| UNITED STATES | $12.68B+1.1% | $12.54B+0.6% | $12.46B+2.5% | $12.15B+2.4% | $11.86B-1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Becton, Dickinson and Company break its business down?
- Becton, Dickinson and Company (BDX) reports segment other operating expense (income), net as a percent of revenues by business across 5 parts — BioPharma Systems, Connected Care, Interventional, Medical Essentials and Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Becton, Dickinson and Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Becton, Dickinson and Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
